Cargando…
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
Cancer eradication and clinical outcome of immunotherapy depend on tumor cell immunogenicity, including HLA class I (HLA-I) and PD-L1 expression on malignant cells, and on the characteristics of the tumor microenvironment, such as tumor immune infiltration and stromal reaction. Loss of tumor HLA-I i...
Autores principales: | Gil-Julio, Hernani, Perea, Francisco, Rodriguez-Nicolas, Antonio, Cozar, Jose Manuel, González-Ramirez, Amanda Rocío, Concha, Angel, Garrido, Federico, Aptsiauri, Natalia, Ruiz-Cabello, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307653/ https://www.ncbi.nlm.nih.gov/pubmed/34298868 http://dx.doi.org/10.3390/ijms22147248 |
Ejemplares similares
-
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
por: Garrido, Federico, et al.
Publicado: (2017) -
HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
por: Perea, Francisco, et al.
Publicado: (2017) -
Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer
por: Garrido, Maria Antonia, et al.
Publicado: (2021) -
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines
por: Rodríguez, Teresa, et al.
Publicado: (2007) -
Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report
por: Cozar, Jose Manuel, et al.
Publicado: (2008)